| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 1892 | 2003 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study S Collins, T Mertenskoetter, E Loeliger, R Tressler, I Weller, N Friis-Møller, ... Archives of internal medicine 166 (15), 1632-1641, 2006 | 1275 | 2006 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 958 | 2008 |
| Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study G Ferrara, M Losi, R D'Amico, P Roversi, R Piro, M Meacci, B Meccugni, ... The Lancet 367 (9519), 1328-1334, 2006 | 662 | 2006 |
| Common genetic variation and the control of HIV-1 in humans J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ... PLoS genetics 5 (12), e1000791, 2009 | 369 | 2009 |
| Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes B Ledergerber, PLATO collaboration The Lancet 364 (9428), 51-62, 2004 | 354 | 2004 |
| Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease G Monti, M Galli, F Invernizzi, P Pioltelli, F Saccardo, A Monteverde, ... QJM: An International Journal of Medicine 88 (2), 115-126, 1995 | 306 | 1995 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 238 | 2005 |
| Response to combination antiretroviral therapy: variation by age Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... Aids 22 (12), 1463-1473, 2008 | 226 | 2008 |
| All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort … Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... International journal of epidemiology 41 (2), 433-445, 2011 | 220 | 2011 |
| One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects M Airoldi, M Zaccarelli, L Bisi, T Bini, A Antinori, C Mussini, F Bai, ... Patient preference and adherence 4, 115, 2010 | 192 | 2010 |
| Changes in the incidence and predictors of human immunodeficiency virus–associated dementia in the era of highly active antiretroviral therapy K Bhaskaran, C Mussini, A Antinori, AS Walker, M Dorrucci, C Sabin, ... Annals of neurology 63 (2), 213-221, 2008 | 191 | 2008 |
| Combination therapy for carbapenem-resistant Gram-negative bacteria M Paul, Y Carmeli, E Durante-Mangoni, JW Mouton, E Tacconelli, ... Journal of Antimicrobial Chemotherapy 69 (9), 2305-2309, 2014 | 186 | 2014 |
| Performance of tests for latent tuberculosis in different groups of immunocompromised patients L Richeldi, M Losi, R D'Amico, M Luppi, A Ferrari, C Mussini, M Codeluppi, ... Chest 136 (1), 198-204, 2009 | 175 | 2009 |
| Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. M Luppi, MF Grazia, G Bonaccorsi, G Longo, F Narni, P Barozzi, ... Leukemia 10 (2), 351-355, 1996 | 148 | 1996 |
| Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study C Mussini, P Pezzotti, JM Miró, E Martinez, JCLB De Quiros, P Cinque, ... Clinical infectious diseases 38 (4), 565-571, 2004 | 139 | 2004 |
| Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy A Antinori, D Larussa, A Cingolani, P Lorenzini, S Bossolasco, MG Finazzi, ... Clinical infectious diseases 39 (11), 1681-1691, 2004 | 137 | 2004 |
| Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ... The Lancet infectious diseases 16 (5), 565-575, 2016 | 131 | 2016 |
| Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome A Cossarizza, C Mussini, N Mongiardo, V Borghi, A Sabbatini, ... Aids 11 (1), 19-26, 1997 | 131 | 1997 |
| Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital A Bedini, C Venturelli, C Mussini, G Guaraldi, M Codeluppi, V Borghi, ... Clinical microbiology and infection 12 (1), 75-80, 2006 | 129 | 2006 |
